Controlled Level EVERolimus in Acute Coronary Syndromes

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT01529554

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01529554
Other papers using this trial's data
  • Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial American heart journal, 2022-05 DOI, PubMed 35092722
  • Mammalian Target of Rapamycin Inhibition in Patients With ST-Segment Elevation Myocardial Infarction Journal of the American College of Cardiology, 2022-11-08 DOI, PubMed 36049557
  • Microcirculatory Resistance After Primary Percutaneous Coronary Intervention Predicts Residual Myocardial Damage and Scar Formation Journal of the American Heart Association, 2025-02-18 DOI, PubMed 39921502, PMC12074727 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01529554. Randomized; quadruple masking; primary purpose treatment. Start 2015-01-08 (actual); primary completion 2021-11-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Controlled Level EVERolimus in Acute Coronary Syndromes
Acronym
CLEVER-ACS
Condition
Acute Coronary Syndromes
Intervention (Drug)
Everolimus
Intervention (Drug)
Placebo
Lead sponsor
University of Zurich (class: other)
Collaborator
Swiss National Science Foundation (class: other)
Collaborator
Novartis (class: industry)

Record details

Record id
cardio:ct-nct01529554
Content hash
2cbb5ed1f978cb8d809a53ffd5545ef8ec8212ff8afdcdfc29c4e10f53dd66fe